Additional file 1 of Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis

Autor: Jairath, Vipul, Cohen, Russell D., Loftus, Edward V., Candela, Ninfa, Lasch, Karen, Schultz, Bob G.
Rok vydání: 2023
DOI: 10.6084/m9.figshare.22610980.v1
Popis: Additional file 1. Supplementary Table 2. Costs Per Infusion by Site-of-Care. Supplementary Figure 1. Systematic Literature Review Search Terms and PRISMA Diagrams. Supplementary Figure 2. Cost Per Responder at 52 Weeks Based on a Sensitivity Analysis Incorporating Dose-Escalation Costs for Patients With UC Treated With an Advanced Therapy. Supplementary Figure 3. Cost Per Remitter at 52 Weeks Based on a Sensitivity Analysis Incorporating Dose Escalation Costs for Patients With UC Treated With an Advanced Therapy. Supplementary Figure 4. Cost Per Responder at 52 Weeks Based on a Sensitivity Analysis Incorporating Site-of-Care Costs for Patients With UC Treated With an Advanced Therapy. Supplementary Figure 5. Cost Per Remitter at 52 Weeks Based on a Sensitivity Analysis Incorporating Site-of-Care Costs for Patients With UC Treated With an Advanced Therapy.
Databáze: OpenAIRE